Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.260 -0.110 (-3.26%)
Streaming Delayed Price Updated: 1:17 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
GoodRx (GDRX) Q3 Earnings Report Preview: What To Look For
Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting earnings this Tuesday after market close. Here’s what to expect. 
Via StockStory
Healthcare Technology Stocks Q2 Highlights: Tandem Diabetes (NASDAQ:TNDM)
Looking back on healthcare technology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Tandem Diabetes (NASDAQ:TNDM) and its peers. 
Via StockStory
Mark Cuban Isn't Convinced TrumpRx Is Going To 'Change The Game' But He's Giving Them 'Credit For Trying'
Billionaire entrepreneur Mark Cuban offered rare praise for the Trump administration's push to lower prescription drug costs, calling its TrumpRx initiative "a good start," while still acknowledging... 
Via Benzinga
Topics Government
GoodRx (GDRX): Buy, Sell, or Hold Post Q2 Earnings?
Over the past six months, GoodRx’s stock price fell to $3.94. Shareholders have lost 9.8% of their capital, which is disappointing considering the S&P 500 has climbed by 30.6%. This was partly due to... 
Via StockStory
Topics Stocks Supply Chain
GoodRx Stock Buzzes As TrumpRx Drug Pricing Shake-Up Draws BofA Warning On Core Business Model
Via Stocktwits
3 Cash-Producing Stocks with Warning Signs
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch
Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers. 
Via Benzinga
Topics Government
Q2 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology industry, including GoodRx (NASDAQ:GDRX) and its peers. 
Via StockStory
Amgen To Sell Cholesterol Drug For Approximately 60% Discount
Patients can purchase Repatha at a discount through Amgen’s direct-to-patient program, AmgenNow. 
Via Stocktwits
Topics Government
1 Healthcare Stock with Exciting Potential and 2 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
Why GoodRx (GDRX) Stock Is Up Today
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 1.4% in the afternoon session after the stock's positive momentum continued following a potential partnership with TrumpRx and an expanded... 
Via StockStory
Topics World Trade
Clover Health, GoodRx, Cardinal Health, McKesson, and Humana Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
2 of Wall Street’s Favorite Stocks Worth Investigating and 1 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Why GoodRx (GDRX) Shares Are Sliding Today
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) fell 4.9% in the afternoon session after a report on the U.S. job market raised concerns about a potential recession. 
Via StockStory
Topics Economy Initial Public Offering Stocks
Why GoodRx (GDRX) Stock Is Up Today
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.1% in the morning session after investor enthusiasm continued following its recent partnership with Danish pharmaceutical giant Novo... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering
GoodRx (GDRX) Stock Is Up, What You Need To Know
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.7% in the afternoon session after investor enthusiasm continued following its recent partnership with Danish pharmaceutical giant Novo... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers
Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses. 
Via Benzinga
Topics ETFs
Noodles, GoodRx, Micron, Custom Truck One Source, and CarMax Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
In today's session, these stocks are experiencing unusual volume.
On Wednesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
What's Going On With Hims & Hers Shares Today?
Hims & Hers Health shares are trading lower Tuesday after GoodRx announces a collaboration with Novo Nordisk. 
Via Benzinga
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk
Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results. 
Via Benzinga
GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?
GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new partnership with Novo Nordisk. 
Via Benzinga
GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access
GoodRx stock rose 5.08% after it partnered with Novo Nordisk to offer Ozempic and Wegovy at a flat $499 monthly price for self-paying patients. 
Via Benzinga
Intel, Palo Alto Networks, Goodrx, Applied Digital And Duolingo: Why These 5 Stocks Are On Investors' Radars Today
The stock market presented a mixed picture on Friday, with the S&P 500 and the Dow Jones Industrial Average indices closing lower. 
Via Benzinga
Topics Stocks
What's going on in today's session
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Why GoodRx (GDRX) Stock Is Trading Up Today
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company announced a collaboration with pharmaceutical giant Novo Nordisk to offer the popular... 
Via StockStory
Topics Artificial Intelligence Economy Initial Public Offering
Stocks Muted Ahead Trump-Zelenskyy Meeting, First Solar Jumps: What's Moving Markets Monday?
Investor risk sentiment paused at the start of the week, as markets awaited details expected to emerge later when President Donald Trump meets with Ukrainian President Volodymyr Zelenskyy and European... 
Via Benzinga
Topics Government
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August
 
Via Benzinga
Dayforce, Applied Digital, GoodRx, First Solar, TeraWulf: Stocks Making The Biggest Moves Today
Dayforce shares skyrocketed 26% in Monday’s midday trade after reports suggested that private equity firm Thoma Bravo is in talks to acquire the human resources firm. 
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.